3.5.1.13 additional information - - 667330 3.5.1.13 additional information - substrate specificity, initial reaction rates, overview 667928 3.5.1.13 0.00002 - source tissue: cancerous gut 678541, 679183 3.5.1.13 0.00007 - source tissue: blood serum 678541, 679183 3.5.1.13 0.00018 - source tissue: healthy gut 678541, 679183 3.5.1.13 0.00018 - source tissue: kidney 678541, 679183 3.5.1.13 0.0024 - source tissue: cancerous gut 678541 3.5.1.13 0.0055 - source tissue: healthy gut 678541 3.5.1.13 0.006 - source tissue: blood serum 678541 3.5.1.13 0.0078 - source tissue: kidney 678541 3.5.1.13 0.016 - - 208979 3.5.1.13 0.046 - liver enzyme 208977 3.5.1.13 0.319 - substrate: o-nitroacetanilide 697902 3.5.1.13 0.328 - control serum samples from patients with normal levels of butyrylcholinesterase 679287 3.5.1.13 0.331 - control serum samples from patients with normal levels of butyrylcholinesterase 679287 3.5.1.13 0.455 - control serum samples from patients with normal levels of butyrylcholinesterase 679287 3.5.1.13 0.55 - recombinant purified His-tagged enzyme, pH 8.0, 35°C, substrate 3',4'-dichloropropionanilide 733190 3.5.1.13 0.621 - control serum samples from patients with normal levels of butyrylcholinesterase 679287 3.5.1.13 0.649 - serum samples of patients with liver dysfunction 679287 3.5.1.13 0.665 - serum samples of patients with liver dysfunction 679287 3.5.1.13 0.69 - recombinant purified His-tagged enzyme, pH 8.0, 35°C, substrate 2',6'-dimethylacetanilide 733190 3.5.1.13 0.741 - serum samples of patients with liver dysfunction 679287 3.5.1.13 0.804 - serum samples of patients with liver dysfunction 679287 3.5.1.13 0.806 - serum samples of patients with liver dysfunction 679287 3.5.1.13 0.81 - - 208986 3.5.1.13 0.87 - recombinant purified His-tagged enzyme, pH 8.0, 35°C, substrate p-acetotoluidide 733190 3.5.1.13 0.904 - serum samples of patients with liver dysfunction 679287 3.5.1.13 0.981 - control serum samples from patients with normal levels of butyrylcholinesterase 679287 3.5.1.13 1.061 - serum samples of patients with pathological liver dysfunction 679287 3.5.1.13 1.116 - serum samples of patients with pathological liver dysfunction 679287 3.5.1.13 1.236 - serum samples of patients with liver dysfunction 679287 3.5.1.13 1.381 - serum samples of patients with pathological liver dysfunction 679287 3.5.1.13 1.41 - serum enzyme 208977 3.5.1.13 1.477 - serum samples of patients with pathological liver dysfunction 679287 3.5.1.13 1.503 - serum samples of patients with pathological liver dysfunction 679287 3.5.1.13 2.4 - - 696876 3.5.1.13 2.809 - serum samples of patients with pathological liver dysfunction 679287 3.5.1.13 3.244 - serum samples of patients with pathological liver dysfunction 679287 3.5.1.13 3.785 - serum samples of patients with pathological liver dysfunction 679287 3.5.1.13 4.068 - serum samples of patients with pathological liver dysfunction 679287 3.5.1.13 20 - 4-nitroacetanilide, pH 7.0, 25°C 720273 3.5.1.13 27.45 - - 208996 3.5.1.13 39.8 - N-(3,4-dichlorophenyl)propanamide, pH 7.0, 35°C 718672 3.5.1.13 39.8 - purified recombinant His6-tagged PamH, pH 7.0, 35°C 718672 3.5.1.13 319.2 - - 208973